Is Veerhealth Care Ltd (NIYATILEAS) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Veerhealth Care Ltd is a below average quality company .

Is Veerhealth Care Ltd (NIYATILEAS) undervalued or overvalued?

The key valuation ratios of Veerhealth Care Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Veerhealth Care Ltd (NIYATILEAS) share price return in the past 10 years?

Veerhealth Care Ltd share price has appreciated 9.9% annually (CAGR) over the past ten years.

Is Veerhealth Care Ltd (NIYATILEAS) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Veerhealth Care Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Veerhealth Care Ltd (NIYATILEAS)?

Company share prices are keep on changing according to the market conditions. The current trading price of Veerhealth Care Ltd (NIYATILEAS) on 17-Apr-2026 16:59:59 at 16:59 is 19.98.

What is the P/E ratio of Veerhealth Care?

The latest standalone P/E ratio of Veerhealth Care as of 17-Apr-2026 is 50.20.

What is the P/B ratio of Veerhealth Care Ltd (NIYATILEAS)?

The latest standalone P/B ratio of Veerhealth Care Ltd (NIYATILEAS) as of 17-Apr-2026 is 1.73.

What is the 52-week high and low of Veerhealth Care Ltd (NIYATILEAS)?

The 52-week high of Veerhealth Care Ltd (NIYATILEAS) is Rs. 23.77 and the 52-week low is Rs. 11.81.

Veerhealth Care Ltd (NIYATILEAS) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Veerhealth Care Ltd (NIYATILEAS)
Brand: Veerhealth Care

Veerhealth Care Ltd (NIYATILEAS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 511523 NSE: NIYATILEAS | Trading | Small Cap

Veerhealth Care Ltd (NIYATILEAS)

BSE: 511523 NSE: NIYATILEAS

Key Metrics

Market Cap

₹40 Cr.

P/E Ratio

50.20

Price to Book (P/B)

1.73

Price to Sales (P/S)

1.87

EV/EBITDA

17.17

Return on Capital Employed (ROCE)

3.15%

Current Price

₹20

Return on Equity (ROE)

1.78%

Return on Assets (ROA)

1.26%

Operating Profit Margin

2.8%

Net Profit Margin

2.35%

Gross Profit Margin

8.5%

Book Value per Share

₹11.6

Sales Growth (YoY)

26.1%

Sales Growth (3 Years)

20.07%

Operating Profit Growth (1 Year)

-24.59%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

-4.88%

52-Week Low / High

₹12 / 24

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

31.50%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Veerhealth Care Ltd?

Veerhealth Care Ltd revenue growth is 26.1% for FY-2025 , which is above its 5 year CAGR of 7.3% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of Veerhealth Care Ltd?

Promoters hold 31.50% of the Veerhealth Care Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Veerhealth Care Ltd vs industry peers?

Veerhealth Care Ltd revenue CAGR is 7.28% , compared to the industry median CAGR of 0% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Veerhealth Care Ltd belong to?

Veerhealth Care Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.

Q.1 Stock return of Veerhealth Care Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 9.4% based on the current price.

DeciZen - make an informed investing decision on Veerhealth Care

Based on:

Data

M-Cap below 100cr DeciZen not available

Veerhealth Care stock performance

Key Ratios

Is Veerhealth Care Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	1.1%	1%	2.4%	2.9%	5.5%	5%	2.2%	6.3%	6%	3.2%	-
Value Creation Index ⓘ	-0.9	-0.9	-0.8	-0.8	-0.6	-0.7	-0.9	-0.6	-0.6	-0.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	2.1	1.9	5.2	6	11.7	10.6	9.6	13.3	13.2	16.7	21
Sales YoY Gr.	-	-9.4%	169.3%	15.7%	96.2%	-9.8%	-9%	37.8%	-0.4%	26.1%	-
Adj EPS ⓘ	0	0	0.1	0.1	0.2	0.3	-0.1	0.8	0.2	0.2	0.4
YoY Gr.	-	100%	400%	10%	109.1%	17.4%	-118.5%	NA	-74.7%	0%	-
BVPS (₹) ⓘ	9.2	9.3	9.5	9.6	9.9	10.1	10.1	10.7	10.9	11.1	11.6
Adj Net Profit ⓘ	0	0	0.1	0.2	0.3	0.4	-0.1	1.6	0.4	0.4	1
Cash Flow from Ops. ⓘ	-0	1.7	1.8	2	-0.4	1	1.8	-0.7	2.9	-0.4	-
Debt/CF from Ops. ⓘ	-3604	-0.1	0.7	0.5	-7	1.7	0	0	0	-12.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	25.8%	7.3%	20.1%	26.1%
Adj EPS ⓘ	39.5%	-2.8%	NA	0%
BVPSⓘ	2.1%	2.3%	3.4%	1.7%
Share Price	9.9%	34.7%	24.5%	25.4%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	0.1	0.2	1.1	1.2	2.4	2.7	-0.5	9	1.9	1.8	3.5
Op. Profit Mgn % ⓘ	-1	-18.9	-2.4	7.4	5.8	-0.6	-8.6	3.7	4.6	2.8	7.3
Net Profit Mgn % ⓘ	0.4	1.2	2.7	2.6	2.7	3.6	-0.8	11.9	3.1	2.4	3.8
Debt to Equity ⓘ	0.1	-0	0.1	0.1	0.2	0.1	0	0	0	0.2	-
Working Cap Days ⓘ	1,943	2,072	685	525	262	305	348	259	353	313	83
Cash Conv. Cycle ⓘ	274	374	125	42	18	64	75	71	90	68	51

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0.4	-
TTM Sales (₹ Cr.)	21.3	-
BVPS (₹) ⓘ	11.6	-
Reserves (₹ Cr.) ⓘ	3	-
P/BV ⓘ	1.73	-
PE ⓘ	50.20	-

From the Market
52 Week Low / High (₹)	11.81 / 23.77
All Time Low / High (₹)	0.25 / 43.75
Market Cap (₹ Cr.)	40
Equity (₹ Cr.)	20
Face Value (₹)	10
Industry PE ⓘ	25.8

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Veerhealth Care - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	2.12	1.92	5.17	5.98	11.73	10.58	9.63	13.27	13.22	16.67
Operating Expenses ⓘ +	2.14	2.28	5.29	5.54	11.05	10.64	10.46	12.78	12.61	16.21
Manufacturing Costs	0.10	0.12	0.19	0.18	0.93	1.31	0.93	0.61	0.46	1.07
Material Costs	0.92	1.16	3.68	3.79	7.88	7.52	6.92	9.23	9.13	11.40
Employee Cost	0.47	0.58	0.57	0.47	0.80	0.83	0.88	0.90	1.31	1.58
Other Costs ⓘ	0.66	0.42	0.85	1.11	1.44	0.99	1.73	2.04	1.72	2.16
Operating Profit ⓘ	-0.02	-0.36	-0.12	0.44	0.68	-0.06	-0.83	0.49	0.61	0.46
Operating Profit Margin (%)	-1.0%	-18.9%	-2.4%	7.4%	5.8%	-0.6%	-8.6%	3.7%	4.6%	2.8%
Other Income ⓘ +	0.38	0.72	0.72	0.29	0.48	1.33	1.68	1.25	1.39	1.22
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.13	0.10	0.07	0.03	0.19	0.22	0.09	0	0.01	0.26
Depreciation ⓘ	0.21	0.23	0.27	0.32	0.32	0.47	0.52	0.62	0.71	0.91
Profit Before Tax ⓘ	0.02	0.03	0.25	0.38	0.65	0.58	0.24	1.12	1.28	0.51
Tax ⓘ	0.01	0.01	0.11	0.22	0.33	0.20	0.31	-0.47	0.88	0.12
Profit After Tax	0.01	0.02	0.14	0.16	0.32	0.38	-0.07	1.58	0.41	0.39
PAT Margin (%)	0.4%	1.2%	2.7%	2.6%	2.7%	3.6%	-0.8%	11.9%	3.1%	2.4%
Adjusted EPS (₹)	0.0	0.0	0.1	0.1	0.2	0.3	-0.1	0.8	0.2	0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	12.82	12.85	13.10	13.28	13.76	14.04	13.95	21.43	21.84	22.22
Share Capital ⓘ	6.93	6.93	6.93	6.93	6.93	6.93	6.93	10	20	20
Reserves ⓘ	5.88	5.92	6.17	6.35	6.82	7.11	7.02	11.43	1.84	2.22
Debt +	1.08	-0.17	1.21	0.94	2.48	1.73	0	0	0	4.91
Long Term Debt	0.67	0.44	0.21	0	2.04	1.41	0	0	0	4.20
Short Term Debt	0.41	-0.61	1.01	0.94	0.44	0.32	0	0	0	0.71
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.08	0.22	0.19	1.57	0.84	0.92	2.32	0.55	2.16	2.62
Others Liabilities ⓘ	0.14	0.16	0.23	0.36	0.91	2.04	3.88	3.27	4.12	4.02
Total Liabilities ⓘ	14.12	13.06	14.74	16.16	17.98	18.73	20.15	25.25	28.12	33.77
Fixed Assets
Net Fixed Assets ⓘ +	2.71	2.52	5.54	5.46	9.45	9.48	10.54	12.01	11.97	19.87
Gross Block	3.07	3.11	6.41	6.62	10.88	11.37	12.96	15.05	16.03	24.84
Accumulated Depreciation	0.36	0.59	0.86	1.16	1.43	1.89	2.42	3.04	4.06	4.97
CWIP ⓘ	0	0	0.24	2.19	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0.03
Inventories	1.12	1.53	0.94	0.84	1.23	1.66	2.12	2.61	1.40	2.44
Trade Receivables	0.89	0.61	0.92	0.74	0.94	1.54	1.54	1.84	3.92	3.21
Cash Equivalents	0.10	0.02	0.08	0.18	0.02	0.10	0.40	3.61	0.24	1.16
Others Assets ⓘ	9.30	8.37	7.02	6.75	6.35	5.94	5.54	5.19	10.59	7.05
Total Assets ⓘ	14.12	13.06	14.74	16.16	17.98	18.73	20.15	25.25	28.12	33.77

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-0	1.69	1.76	1.98	-0.36	1	1.81	-0.70	2.90	-0.39
PBT ⓘ	0.02	0.03	0.25	0.38	0.65	0.47	0.26	1.05	1.29	0.62
Adjustment ⓘ	-0.27	-0.07	-0.09	0.32	0.21	0.37	0.10	0.53	0.47	0.73
Changes in Working Capital ⓘ	0.24	0.95	1.7	1.41	-1.15	0.39	1.49	-2.08	1.42	-1.65
Tax Paid ⓘ	0	0.78	-0.10	-0.13	-0.06	-0.23	-0.04	-0.20	-0.28	-0.09
Cash Flow From Investing Activity ⓘ +	-0.01	-0.44	-3.02	-1.90	-1.67	-0.09	-1.09	-1.79	-0.28	-8.20
Capex	-0.76	-0.03	-3.54	-2.19	-2.12	-0.50	-1.58	-2.09	-0.67	-8.81
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.75	-0.40	0.52	0.29	0.46	0.41	0.49	0.30	0.40	0.61
Cash Flow From Financing Activity ⓘ +	0	-1.33	1.31	0.02	1.85	-0.83	-0.42	5.69	-5.99	9.52
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	5.90	0	0
Net Proceeds from Borrowing ⓘ	0	-0.21	-0.23	-0.21	2.04	-0.63	-1.41	0	0	4.20
Interest Paid ⓘ	0	-0.10	-0.07	-0.03	-0.19	-0.22	-0.09	-0.14	-0.16	-0.44
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	-1.02	1.62	0.27	0	0.02	1.08	-0.06	-5.83	5.76
Net Cash Flow ⓘ	-0.01	-0.08	0.06	0.10	-0.17	0.09	0.30	3.21	-3.37	0.92

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0.07	0.18	1.06	1.2	2.35	2.73	-0.53	8.94	1.88	1.78
ROCE (%)	1.13	1	2.38	2.89	5.5	4.97	2.17	6.32	5.96	3.15
Asset Turnover Ratio	0.15	0.14	0.37	0.39	0.69	0.58	0.5	0.58	0.5	0.54
PAT to CFO Conversion(x)	-0	84.5	12.57	12.38	-1.13	2.63	N/A	-0.44	7.07	-1
Working Capital Days
Receivable Days	152	142	54	51	26	43	59	46	79	78
Inventory Days	133	253	87	54	32	50	72	65	55	42
Payable Days	37	47	20	85	56	43	85	57	54	76

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Veerhealth Care Ltd FAQs

The current trading price of Veerhealth Care on 17-Apr-2026 16:59 is ₹19.98.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Veerhealth Care stood at ₹39.96 Cr

The latest P/E ratio of Veerhealth Care as of 16-Apr-2026 is 50.20.

The latest P/B ratio of Veerhealth Care as of 16-Apr-2026 is 1.73.

The 52-week high of Veerhealth Care is ₹23.77 and the 52-week low is ₹11.81.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Veerhealth Care is ₹21.34 ( Cr.) .

About Veerhealth Care Ltd

Veerhealth Care (Formerly known as Niyati Industries) was originally incorporated on July 10, 1992 as Niyati Leasing Limited. From July 15, 1993 the Company had begun the business in the field of Investment and Finance.

In 2013, the management of the company decided to diversify the business activities and changed its main object to Pharma sector and new name of the company is VeerHealth Care. In 2020, the company started operations in cosmetic manufacturing.

The company produces Intensive research based quality products with Expert guidance and enormous experience of renowned Vaid of Mumbai, Dr. Vinod C. Mehta, an Ayurvedic practioner since 30 years and Dr. Rajiv Bhirud, anexpert in formulations of cosmetic and personal care products.

The company is well-equipped with state-of-the-art manufacturing facilities and skilled personnel to ensure optimum utilization of resources with the best quality product.

Business area of the company

The company is engaged in the business of trading and manufacturing and marketing research-based Ayurvedic medicines.

Products of the company

Skincare
Bodycare
Haircare
Fragrances
Healthcare
Oralcare
Mens Care
Gifting
Combos
Accessories

Certifications

Ayurvedic Mfg Lic
Ayurvedic Gmp
Cosmetic Mfg Lic
Cosmetic Gmp
ISO 9001:2015
AEO Certificate

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Veerhealth Care Ltd (NIYATILEAS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Veerhealth Care Share Price